These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10454000)

  • 41. TCV-309, a novel platelet activating factor antagonist, inhibits leukocyte accumulation and protects against splanchnic artery occlusion shock.
    Canale P; Squadrito F; Altavilla D; Ioculano M; Zingarelli B; Campo GM; Urna G; Sardella A; Squadrito G; Caputi AP
    Agents Actions; 1994 Oct; 42(3-4):128-34. PubMed ID: 7879698
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The mediators involved in endotoxin-induced vascular permeability increase in the rat skin and their interactions.
    Ueno A; Tokumasu T; Naraba H; Oh-ishi S
    Jpn J Pharmacol; 1996 Apr; 70(4):285-90. PubMed ID: 8774757
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The increase in the steady-state level of major histocompatibility complex mRNA in the host peripheral T lymphocytes due to ischaemia-reperfusion injury.
    Nikbakht-Sangari M; Qayumi AK; Duronio V
    Transpl Immunol; 1999 Jun; 7(2):107-13. PubMed ID: 10544441
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Possible role of platelet-activating factor in embryonic signaling during oviductal transport in the hamster.
    Velasquez LA; Aguilera JG; Croxatto HB
    Biol Reprod; 1995 Jun; 52(6):1302-6. PubMed ID: 7632839
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dual-color flow cytometric analysis of phenotype, activation marker expression, and proliferation of mitogen-stimulated bovine lymphocyte subsets.
    Quade MJ; Roth JA
    Vet Immunol Immunopathol; 1999 Jan; 67(1):33-45. PubMed ID: 9950352
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Control of human T cell proliferation by platelet-activating factor.
    Behrens TW; Goodwin JS
    Int J Immunopharmacol; 1990; 12(2):175-84. PubMed ID: 2329011
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of prostaglandin of E, F and I series, leukotriene C and platelet activating factor on amylase release from isolated rat pancreatic acini.
    Jaworek J; Konturek SJ
    J Physiol Pharmacol; 1993 Dec; 44(4):365-81. PubMed ID: 7510150
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of platelet-activating factor receptors on canine T lymphocytes.
    Mangino MJ; Murphy MK; Weiss A; Anderson CB
    J Immunol; 1993 Nov; 151(10):5310-8. PubMed ID: 8228226
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of cardiac function during hyperacute rejection: effects of PAF antagonist, TXA(2) inhibitor/antagonists, and nitroglycerin.
    Miyatake T; Kubota S; Miyazaki K; Watanabe S; Mafune N; Murashita T; Yasuda K
    Transplant Proc; 2000 Aug; 32(5):999-1000. PubMed ID: 10936319
    [No Abstract]   [Full Text] [Related]  

  • 50. Variation in expression of MHC class II antigens on horse lymphocytes determined by MHC haplotype.
    Barbis DP; Bainbridge D; Crump AL; Zhang CH; Antczak DF
    Vet Immunol Immunopathol; 1994 Jul; 42(1):103-14. PubMed ID: 7975179
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Platelet-activating factor (PAF) receptor antagonists inhibit mitogen-induced human peripheral blood T-cell proliferation.
    Patrignani P; Valitutti S; Aiello F; Musiani P
    Biochem Biophys Res Commun; 1987 Oct; 148(2):802-10. PubMed ID: 2825672
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment with the platelet-activating factor antagonist TCV-309 in patients with severe systemic inflammatory response syndrome: a prospective, multi-center, double-blind, randomized phase II trial.
    Froon AM; Greve JW; Buurman WA; van der Linden CJ; Langemeijer HJ; Ulrich C; Bourgeois M
    Shock; 1996 May; 5(5):313-9. PubMed ID: 9156785
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of major histocompatibility complex class II antigen in neoplastic cells of canine cutaneous histiocytoma.
    Kipar A; Baumgärtner W; Kremmer E; Frese K; Weiss E
    Vet Immunol Immunopathol; 1998 Mar; 62(1):1-13. PubMed ID: 9618864
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence for accessory cell function by class II MHC antigen-expressing airway epithelial cells.
    Kalb TH; Chuang MT; Marom Z; Mayer L
    Am J Respir Cell Mol Biol; 1991 Apr; 4(4):320-9. PubMed ID: 2015098
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ex vivo inhibition of beta-thromboglobulin release following administration to man of ABT-299, a novel prodrug of a potent platelet activating factor antagonist.
    Albert DH; Magoc TJ; Menacherry SD; Morgan DW; Sun E; Reyes AE; Kleinert HD; Carter GW; Summers JB
    Inflamm Res; 1997 Jul; 46(7):272-7. PubMed ID: 9266276
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of TCV-309, a novel platelet activating factor antagonist, on hemodynamics in dogs with endotoxin-induced shock.
    Okano S; Tagawa M; Urakawa N
    J Vet Med Sci; 1995 Apr; 57(2):385-7. PubMed ID: 7492672
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of platelet-activating factor and prostanoids in hemodynamic changes in rat experimental endotoxic shock.
    Ebara T; Miura K; Matsuura T; Imanishi M; Yamano Y; Kim S; Iwao H
    Jpn J Pharmacol; 1996 Jul; 71(3):247-53. PubMed ID: 8854207
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The immunogenic potential of human fetal retinal pigment epithelium and its relation to transplantation.
    Rezai KA; Semnani RT; Patel SC; Ernest JT; van Seventer GA
    Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2662-71. PubMed ID: 9375586
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of the platelet-activating factor inhibitor TCV-309 on reperfusion injury in a canine model of ischemic lung.
    Kawahara K; Tagawa T; Takahashi T; Akamine S; Nakamura A; Yamamoto S; Muraoka S; Tomita M
    Transplantation; 1993 Jun; 55(6):1438-9. PubMed ID: 8516834
    [No Abstract]   [Full Text] [Related]  

  • 60. Role of platelet activating factor on severity of ischemic colitis.
    Nagahata Y; Azumi Y; Akimoto T; Nomura H; Ichihara T; Idei H; Kuroda Y
    Dis Colon Rectum; 1999 Feb; 42(2):218-24. PubMed ID: 10211499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.